Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07451210 · ClinicalTrials.gov registry record · NA
Evaluating the Efficacy of Blood Flow Restriction Therapy in a Randomized Clinical Trial for Postoperative Rehabilitation Following Ankle Ligament Reconstruction
A NA study of Physical Therapy and Ankle Reconstruction, sponsored by Texas Tech University Health Sciences Center.
- Recruiting
- Registry status
- NA
- Development phase
- 105
- Enrollment target
- 5
- Study locations
NCT07451210: Recruiting NA study of Physical Therapy and Ankle Reconstruction, sponsored by Texas Tech University Health Sciences Center.
NCT07451210 is a NA study of Physical Therapy and Ankle Reconstruction that is actively recruiting participants, run by Texas Tech University Health Sciences Center. The registered enrollment target is 105 participants, below the 478-participant average among 8 other Physical Therapy trials with a reported enrollment target (78% lower). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07451210, a NA study of Physical Therapy and Ankle Reconstruction, is actively recruiting participants, sponsored by Texas Tech University Health Sciences Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
- 5
- Study locations
Study Summary
The goal of this single blinded clinical trial is to investigate blood flow restriction (BFR) for rehabilitation of patients after ankle ligament reconstruction surgery. Outcome measures will be compared between the standard of care (SoC) and BFR groups at the end of the study intervention. Following standard surgical procedures, both groups will undergo physical therapy by a certified physical therapist for a minimum of 6 weeks. The SOC group will receive standard physical therapy without use of BFR. The BFR group will receive physical therapy with BFR. Outcome measures of interest will be taken at the start of physical therapy (time 0) and at the end of physical therapy (minimum of 6 weeks of PT) for both groups. Outcome measures of interest include: * muscle atrophy; * ankle function; * fatigability/manual muscle testing; * pain scores; * cardiovascular effects (heart rate, blood pressure).
Primary Outcome
Measurement location: maximal circumference of the gastrocnemius muscle Unit: cm Range: varies by participant
Conditions Studied
Interventions
- DEVICE blood flow restriction
Study Locations (5)
Texas
- Physical Therapy Today (PTT) - Lubbock
- University Medical Center - Lubbock
- Northstar Surgery Center - Lubbock
- The Center for Orthopedic Surgery - Lubbock
- Texas Tech University Health Sciences Center - Lubbock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2026-03-01 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT07451210 shows while recruiting
NCT07451210 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 478-participant average among 8 other Physical Therapy trials with a reported enrollment target (78% lower).
The record links to 3 conditions, with Physical Therapy appearing as the primary indexed condition, and to 1 intervention - of which blood flow restriction is the first listed.
NCT07451210 lists 5 locations in 1 state (Texas).
Frequently Asked Questions
What is clinical trial NCT07451210 about?
NCT07451210 is a clinical study titled "Evaluating the Efficacy of Blood Flow Restriction Therapy in a Randomized Clinical Trial for Postoperative Rehabilitation Following Ankle Ligament Reconstruction". The goal of this single blinded clinical trial is to investigate blood flow restriction (BFR) for rehabilitation of patients after ankle ligament reconstruction surgery. Outcome measures will be compared between the standard of care (SoC) and BFR groups at the end of the study intervention. Followi...
What is the current status of trial NCT07451210?
This trial is currently recruiting. It is a NA study. The enrollment target is 105 participants. The study started on 2026-03-01. Estimated completion is 2027-12-31.
What conditions does trial NCT07451210 study?
This clinical trial studies the following conditions: Physical Therapy, Ankle Reconstruction, Blood Flow Restriction Therapy.
What interventions are being tested in trial NCT07451210?
The interventions under investigation include: blood flow restriction (DEVICE).
Who is sponsoring clinical trial NCT07451210?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07451210 being conducted?
This trial has 5 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Physical Therapy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07451210's enrollment target sits among peer trials
105 5th of 8 higher than 4 of 8 other Physical Therapy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Physical Therapy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Is Physical Therapy Clearance Before Arthroplasty Home Discharge Necessary?
RECRUITING · NA
-
Implementation of Neuromuscular Electrical Stimulation After Total Knee Arthroplasty
RECRUITING · NA
-
Arthroscopic Labral Repair Versus Physical Therapy for Tears of the Acetabular Labrum
ACTIVE NOT RECRUITING · NA
-
Art and Physical Therapy in Pediatric HCT
ACTIVE NOT RECRUITING · NA
-
Functional Prehabilitation and Major Elective Surgery
COMPLETED · NA
-
Immersive Physical Therapy in the Neonatal Intensive Care Unit (NICU)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI